Jiacong Guo is the Vice President of Investments at BioTrack Capital. Jiacong has also worked with OnCusp Therapeutics, Innogen, Shanton Pharma, and WuXi Biologics, where they served as the Assistant Director at the CEO Office. Guo has also done investment internships with Hillhouse Capital Management and Bristol Myers Squibb. Jiacong began their career as a Research Assistant at the University of Southern California in 2011.
Jiacong Guo would have completed a four-year undergraduate degree, followed by a two to three year graduate program, culminating in a Doctor of Philosophy (PhD) in Oncology and Cancer Immunotherapy from the University of Southern California.
Jiacong Guo reports to Kevin Chen, Founding Partner. They work with Maggie Ye - Operations Director, Jason Wu - Senior Associate, and Jane Du - Principal.
Sign up to view 0 direct reports
Get started